Mazdutide: A Dual GLP-1/Glucagon Receptor Agonist in Early Clinical Evidence Mazdutide (IBI362) is a novel dual GLP-1 and glucagon receptor agonist designed to integrate appetite suppression with increased energy expenditure
N Engl J Med 387(5):433443 Ashrafizadeh M, Yaribeygi H, Atkin SL, Sahebkar A (2019) Effects of newly introduced antidiabetic drugs on autophagy
For example, in Nile tilapia, animal protein increased GM Proteobacteria and reduced Bacteroidetes and Cetobacterium (Pereira et al., 2024)
Holistic-minded practitioners, meanwhile, have long suspected candida overgrowth is a possible trigger for a host of nonspecific symptoms, including fatigue, bloating, eczema, dandruff, sugar cravings, weight gain, and brain fog
Luchsinger JA, Perez T, Chang H, Mehta P, Steffener J, Pradabhan G, et al